[1] Gauthier C, Leblais V, Kobzik L, et al. The negative inotropic effect of beta3-adrenoceptor stimulation is mediated by activation of a nitric oxide synthase pathway in human ventricle[J]. J Clin Invest, 1998, 102(7):1377-1384. [2] Gauthier C, Tavernier G, Charpentier F, et al. Functional beta3-adrenoceptor in the human heart[J]. J Clin Invest, 1996, 98(2):556-562. [3] Trochu JN, Leblais V, Rautureau Y, et al. Beta 3-adrenoceptor stimulation induces vasorelaxation mediated essentially by endothelium-derived nitric oxide in rat thoracic aorta[J]. Br J Pharmacol, 1999, 128(1):69-76. [4] Rautureau Y, Toumaniantz G, Serpillon S, et al. Beta 3-adrenoceptor in rat aorta:molecular and biochemical characterization and signalling pathway[J]. Br J Pharmacol, 2002, 137(2):153-161. [5] Brahmadevara N, Shaw AM, MacDonald A. Evidence against beta 3-adrenoceptors or low affinity state of beta 1-adrenoceptors mediating relaxation in rat isolated aorta[J]. Br J Pharmacol, 2003, 138(1):99-106. [6] Brahmadevara N, Shaw AM, MacDonald A. ALpha1-adrenoceptor antagonist properties of CGP 12177A and other beta-adrenoceptor ligands:evidence against beta(3)-or atypical beta-adrenoceptors in rat aorta[J]. Br J Pharmacol, 2004, 142(4):781-787. [7] McLaughlin DP, MacDonald A.Evidence for the existence of ‘atypical’ beta-adrenoceptors (beta 3-adrenoceptors) mediating relaxation in the rat distal colon in vitro[J]. Br J Pharmacol, 1990, 101(3):569-574. [8] McLaughlin DP, MacDonald A. Characterization of catecholamine-mediated relaxations in rat isolated gastric fundus:evidence for an atypical beta-adrenoceptor[J]. Br J Pharmacol, 1991, 103(2):1351-1356. [9] Hristov KL, Cui X, Brown SM, et al. Stimulation of beta3-adrenoceptors relaxes rat urinary bladder smooth muscle via activation of the large-conductance Ca2+-activated K+ channels[J]. Am J Physiol Cell Physiol, 2008, 295(5):C1344-1353. [10] Bardou M, Loustalot C, Cortijo J, et al. Functional, biochemical and molecular biological evidence for a possible beta(3)-adrenoceptor in human near-term myometrium[J]. Br J Pharmacol, 2000, 130(8):1960-1966. [11] 李晓鹏, 赵倩倩, 杨岚. β3肾上腺素能受体对大鼠胸主动脉平滑肌舒缩活动的影响及其机制[J]. 中国应用生理学杂志, 2016, 32(1):69-73. [12] Hartmann P, Zhou Z, Natarelli L, et al. Endothelial Dicer promotes atherosclerosis and vascular inflammation by miRNA-103-mediated suppression of KLF4. Nat Commun, 2016, 7:10521. [13] Cordes KR, Sheehy NT, White MP, et al. miR-145 and miR-143 regulate smooth muscle cell fate and plasticity[J]. Nature, 2009, 460(7256):705-710. [14] Rothman AM, Chico TJ, Lawrie A. MicroRNA in pulmonary vascular disease[J]. Prog Mol Biol Transl Sci, 2014, 124:43-63. [15] Wu WH, Hu CP, Chen XP, et al. MicroRNA-130a mediates proliferation of vascular smooth muscle cells in hypertension[J]. Am J Hypertens, 2011, 24(10):1087-1093. [16] Ji R, Cheng Y, Yue J, et al. MicroRNA expression signa-ture and antisense-mediated depletion reveal an essential role of MicroRNA in vascular neointimal lesion formation[J]. Circ Res, 2007, 100(11):1579-1588. [17] Liu X, Cheng Y, Zhang S, et al. A necessary role of miR-221and miR-222in vascular smooth muscle cell proliferation and neointimal hyperplasia[J]. Circ Res, 2009, 104(4):476-487. |